First-in-class AR-V7/AR-fl small molecule molecular glue degrader for prostate cancer treatmentCANCER RESEARCHIF16.62024-03-221PRE
Novel insights into androgen receptor-variant 7 subnuclear localization and function in castration resistant prostate cancerCANCER RESEARCHIF16.62024-03-220PRE
Varicella-zoster virus reactivation is frequently detected in HIV-infected individuals presenting with strokeJOURNAL OF MEDICAL VIROLOGYIF4.62022-02-177OAAI
MicroRNA-1205 directly binds to FRYL and suppresses aggressive prostate cancerCANCER RESEARCHIF16.62020-08-150PRE
MicroRNA-1205 regulation of FRYL and aggressive prostate cancer in men of African ancestryCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42020-06-010PRE
Active patient and stakeholder engagement was critical to the success of a comparative trial to reduce liver cancer disparities for underserved Asian Americans with HBVCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42020-06-010PRE
Molecular mechanisms of microRNA-1205 in aggressive prostate cancer in men of African ancestryCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42020-06-010PRE
MicroRNA-1205 regulation of FRYL in neuroendocrine prostate cancerCANCER RESEARCHIF16.62019-07-010PRE
MicroRNA-1205 as a tumor suppressor in castration resistant prostate cancerCANCER RESEARCHIF16.62018-07-010PRE
PVT1-derived non-coding RNAs in prostate cancer in men of African ancestryCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42017-02-050PRE
miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectinEXPERIMENTAL CELL RESEARCHIF3.52016-11-0154OAAI
Circulating tumor cells from a syngeneic mouse model of hepatocellular carcinoma demonstrate epithelial-mesenchymal transition, decreased MHC I expression, and increased CCR7 expressionCANCER RESEARCHIF16.62016-07-150PRE
A novel polyisoprenylated cysteinyl amide inhibitor, NSL-BA-055, selectively inhibits proliferation of hepatocellular carcinoma cellsCANCER RESEARCHIF16.62015-08-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向